Clinical Trial Update: Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes the use of microperimetry and optical coherence tomography to monitor treatment with ranibizumab (Lucentis) for diabetic ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN